2 “Buy the Dip” Opportunities in the Current Market

Even after the “90 more days” proclamation, the markets are looking rough.

Depending on how events unfold, they might look rough for months to come. However, this is not necessarily a cause for despair. Bear markets have happened before. And companies that have experienced them are still in business, providing excellent returns for investors.

However, there will be some turbulence in the meantime. That means if you’re confident in a stock, right now could be a great time to buy the dip.

But how do you know a given stock is experiencing just a dip? If you’re focused on the long term, you can trust in our Zen Ratings system to assist in choosing top contenders for your portfolio. By picking out A-rated stocks with a Component Grade of A for Value, you can readily locate potentially excellent undervalued stocks to consider.

I went ahead and did the legwork for you this time. Here are two potential buy the dip stocks to watch:

1. Herbalife Ltd (NYSE: HLF)

While over the last month HLF stock has dropped about 17%, it is currently on the rise once again (however modestly). Nonetheless, now might be the time to buy the dip, given its A Component Grade for Value.

For other reasons to consider the stock, note that:

• Its earnings picture has been looking better in recent months.
• It is still making acquisitions and is actively seeking to dominate the health and wellness market (one that will remain at least partially strong despite some economic turbulence).
• Of additional note for its component grades, it received a B in safety and A in financials. This indicates the HLF is more prepared than the competition for whatever comes.

2. Biomarin Pharmaceutical Inc. (NASDAQ: BMRN)

While over-the-counter supplements and consumer health products are one market, the pharmaceutical and biotech industries are another thing entirely. And while BMRN has had a sharp drop in the last few weeks, that might just mean it’s the perfect time to buy the dip. Despite a shock to the economic system, the fundamentals do not look different for BMRN, and there is potential in its therapies.

Some reasons to consider BMRN include:

• BMRN is currently experiencing cash flow growth and showing earnings growth, with the EPS expected to grow 22% this year. 
• It has a component grade of B for both financials and growth.
• It is better positioned to not be dealt the worst of tariff uncertainty.

Yet these aren’t the only stocks that someone might want to buy the dip on. With WallStreetZen Premium, you’ll have a much easier time keeping track of everything else. You will get an unlimited watchlist, access to all the fundamental information you need, and premium stock ideas pages, such as a list of stocks to sell now and excellent value stocks to buy now.

Additionally, if you’re looking for more of a guiding hand and choices you can trust, Zen Investor will provide you with more direct stock picks and recommendations made by our own Steve Reitmeister. He has more than 40 years of investing experience, and this isn’t the first time he’s seen an uncertain market.

What to Do Next?

• 8 Stock Lists You Need Now >
• See All “A” Rated Stocks with +32.52% Average Annual Return > 
• 4 Step Process to Find More 100%+ Stock Winners >

Want to get in touch? Email us at news@wallstreetzen.com.